RPRX
Royalty Pharma PLC
Price:  
35.51 
USD
Volume:  
8,149,648.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RPRX Relative Valuation

0.2%
Upside

As of 2025-07-09, the Relative Valuation of Royalty Pharma PLC (RPRX) is 35.60 USD. This relative valuation is based on P/E multiples. With the latest stock price at 35.51 USD, the upside of Royalty Pharma PLC based on Relative Valuation is 0.2%.

The range of the Relative Valuation is 34.54 - 36.75 USD.

Range Selected
Trailing P/E multiples 18.2x - 18.7x 18.4x
Forward P/E multiples 20.0x - 21.3x 20.5x
Fair Price 34.54 - 36.75 35.60
Upside -2.7% - 3.5% 0.2%
35.51 USD
Stock Price
35.60 USD
Fair Price

RPRX Relative Valuation - Historical P/E Data

Date P/E
2025-07-08 18.27
2025-07-07 18.31
2025-07-03 18.72
2025-07-02 18.62
2025-07-01 18.46
2025-06-30 18.54
2025-06-27 18.46
2025-06-26 18.15
2025-06-25 18.48
2025-06-24 18.60
2025-06-23 18.22
2025-06-20 17.94
2025-06-18 17.97
2025-06-17 17.78
2025-06-16 18.06
2025-06-13 17.93
2025-06-12 18.15
2025-06-11 17.52
2025-06-10 17.28
2025-06-09 17.18
2025-06-06 17.38
2025-06-05 17.37
2025-06-04 17.21
2025-06-03 17.13
2025-06-02 17.12
2025-05-30 16.92
2025-05-29 16.80
2025-05-28 16.79
2025-05-27 16.82
2025-05-23 16.70
2025-05-22 16.63
2025-05-21 16.89
2025-05-20 17.03
2025-05-19 17.63
2025-05-16 17.51
2025-05-15 17.04
2025-05-14 16.62
2025-05-13 16.89
2025-05-12 17.16
2025-05-09 17.06
2025-05-08 17.03
2025-05-07 16.85
2025-05-06 16.52
2025-05-05 16.98
2025-05-02 16.93
2025-05-01 16.71
2025-04-30 16.89
2025-04-29 16.83
2025-04-28 16.75
2025-04-25 16.57